The webinar series IVDR@noon provides insight and guidance to all interested parties on the implementation of the new European regulation in the field of in-vitro diagnostics, which comes into force in May 2022. Exceptionally, the event will be held in German on January 19. The presentations will be made available in English later. Participation is free of charge for Swiss Medtech members. Non-members can register for a fee of CHF 60. The event will start at 12h00 and end at 13h00.

19 January 2022

12h00 – 13h00

Not flying blind into a supply gap

Analogous to the IVDR in the EU, Switzerland is currently in the process of drafting a new in-vitro diagnostics ordonnance (IvDO), which will come into force in May 2022. Due to the new third-country reality in Switzerland, this will entail higher hurdles, especially for the import and distribution of in-vitro diagnostics. Although the regulation has not yet been finalized, the industry is not completely flying blind. In the webinar on January 19, two experts will report on the latest developments and discussions with the responsible authorities.

Topics and Speakers (in German)

  • Politische Hintergründe, um die IvDV zu verstehen
    Dr. Daniel Delfosse, Swiss Medtech
  • BAG «Runder Tisch» IvDV (24.11.21):
    Zusammenfassung – Einschätzung – Konsequenzen

    Michael Bosshard, Roche Diagnostics (Schweiz) AG / SVDI



Christian Huber

Project Manager

Public Affairs

+41 31 330 97 71



Angela D’Aranno

Project Manager

+41 31 330 97 70


supported by